Summary & Overview
CPT 46505: Anal Sphincter Chemodenervation
CPT code 46505 denotes chemodenervation of the anal sphincter, a targeted injectable procedure used to interrupt neural signaling and relieve sphincter spasm. Nationally, this code represents a specialized therapeutic intervention in colorectal and proctologic care that affects ambulatory surgical and outpatient procedural billing. The code is relevant to hospital outpatient departments, ambulatory surgical centers, and clinic-based procedural billing pathways.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on clinical context, common sites of service, and the administrative framing of the procedure. The publication provides benchmarks and coding context for reimbursement and utilization, highlights typical payer considerations and coding nuances, and summarizes implications for practice workflows and administrative review.
The report outlines: the clinical purpose of CPT code 46505, typical settings where the procedure occurs, payer coverage patterns and benchmarks, and any recent policy or coding considerations that affect billing and claims adjudication. Data not available in the input will be noted where applicable.
Billing Code Overview
CPT code 46505 describes a chemodenervation of the anal sphincter, a procedure in which a provider injects a therapeutic agent into the anal sphincter muscle to interrupt nerve signaling and relieve sphincter spasm. The procedure is delivered to the anal sphincter, a muscular ring surrounding the tip of the anus.
-
Service type: Therapeutic chemodenervation (injective procedure)
-
Typical site of service: Ambulatory surgical center or outpatient procedure room (office or clinic-based procedure)
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient colorectal surgery or gastroenterology clinic with chronic internal anal sphincter hypertonicity or persistent anal fissure refractory to conservative therapy. The patient reports severe anal pain with bowel movements despite stool softeners, topical nitrates or calcium channel blockers, and Sitz baths. After clinical assessment and exclusion of infection, inflammatory bowel disease, or malignancy, the provider recommends chemodenervation of the internal anal sphincter to reduce resting tone and promote fissure healing.
The clinical workflow: the patient is scheduled in an ambulatory procedure room or endoscopy suite. Pre-procedure evaluation includes consent, review of anticoagulation, and brief history and focused exam. The provider administers local anesthesia as needed, then injects botulinum toxin into one or more quadrants of the anal sphincter under direct visualization or palpation. The patient is monitored briefly for adverse effects and discharged with post-procedure instructions and follow-up to assess symptom improvement and wound healing. Typical site of service is an ambulatory surgical center or physician office procedure room.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal, postoperative care included | Use when the service is the usual, expected service by the performing provider without unusual circumstances. |